Ignite Creation Date:
2025-12-25 @ 4:51 AM
Ignite Modification Date:
2026-03-02 @ 4:55 PM
Study NCT ID:
NCT02142218
Status:
NO_LONGER_AVAILABLE
Last Update Posted:
2016-09-29
First Post:
2014-05-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Expanded Access Program With Nivolumab to Treat Melanoma
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-06
Start Date Type:
None
Primary Completion Date:
2018-05
Primary Completion Date Type:
ESTIMATED
Completion Date:
2018-05
Completion Date Type:
ESTIMATED
First Submit Date:
2014-05-16
First Submit QC Date:
None
Study First Post Date:
2014-05-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-09-28
Last Update Post Date:
2016-09-29
Last Update Post Date Type:
ESTIMATED